Literature DB >> 30982685

Perioperative FLOT: new standard for gastric cancer?

Yoon-Koo Kang1, Hyungwoo Cho2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30982685     DOI： 10.1016/S0140-6736(18)33189-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  FLOT Neoadjuvant Chemotherapy Followed by Laparoscopic D2 Gastrectomy in the Treatment of Locally Resectable Advanced Gastric Cancer.

Authors:  Shun Zhang; Dongyi Yan; Qi Sun; Tao Du; Dongliang Cao; Yao Yang; Biao Yuan; Haiqiang Li; Xiaohua Jiang; Chun Song
Journal:  Can J Gastroenterol Hepatol       Date:  2020-05-29

2.  Stage IV Gastric Cancer: The Surgical Perspective of the Italian Research Group on Gastric Cancer.

Authors:  Silvia Ministrini; Maria Bencivenga; Leonardo Solaini; Chiara Cipollari; Silvia Sofia; Elisabetta Marino; Alessia d'Ignazio; Beatrice Molteni; Gianni Mura; Daniele Marrelli; Maurizio Degiuli; Annibale Donini; Franco Roviello; Giovanni de Manzoni; Paolo Morgagni; Guido A M Tiberio
Journal:  Cancers (Basel)       Date:  2020-01-09       Impact factor: 6.639

3.  Preclinical evaluation of exemestane as a novel chemotherapy for gastric cancer.

Authors:  Juan-Cheng Yang; Ning Chang; Deng-Chyang Wu; Wei-Chung Cheng; Wei-Min Chung; Wei-Chun Chang; Fu-Ju Lei; Chung-Jung Liu; I-Chen Wu; Hsueh-Chou Lai; Wen-Lung Ma
Journal:  J Cell Mol Med       Date:  2019-09-26       Impact factor: 5.310

4.  Perioperative Safety and Effectiveness of Neoadjuvant Therapy with Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel Plus Apatinib in Locally Advanced Gastric Cancer.

Authors:  Yonglei Zhang; Bin Zhang; Jinpo Yang; Jindai Zhang; Wei Zhang
Journal:  Cancer Manag Res       Date:  2021-03-10       Impact factor: 3.989

5.  CircPTK2 Suppresses the Progression of Gastric Cancer by Targeting the MiR-196a-3p/AATK Axis.

Authors:  Ling Gao; Tingting Xia; Mingde Qin; Xiaofeng Xue; Linhua Jiang; Xinguo Zhu
Journal:  Front Oncol       Date:  2021-09-15       Impact factor: 6.244

Review 6.  Trial watch: IDO inhibitors in cancer therapy.

Authors:  Julie Le Naour; Lorenzo Galluzzi; Laurence Zitvogel; Guido Kroemer; Erika Vacchelli
Journal:  Oncoimmunology       Date:  2020-06-14       Impact factor: 8.110

7.  Machine-learning model derived gene signature predictive of paclitaxel survival benefit in gastric cancer: results from the randomised phase III SAMIT trial.

Authors:  Raghav Sundar; Nesaretnam Barr Kumarakulasinghe; Yiong Huak Chan; Kazuhiro Yoshida; Takaki Yoshikawa; Yohei Miyagi; Yasushi Rino; Munetaka Masuda; Jia Guan; Junichi Sakamoto; Shiro Tanaka; Angie Lay-Keng Tan; Michal Marek Hoppe; Anand D Jeyasekharan; Cedric Chuan Young Ng; Mark De Simone; Heike I Grabsch; Jeeyun Lee; Takashi Oshima; Akira Tsuburaya; Patrick Tan
Journal:  Gut       Date:  2021-05-12       Impact factor: 23.059
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.